|
RNF5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64568358940187E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.13713549266504E-14 |
| Normal-vs-Stage2 |
5.56170000054479E-07 |
| Normal-vs-Stage3 |
6.47749964777233E-10 |
| Normal-vs-Stage4 |
2.87429999801248E-08 |
| Stage1-vs-Stage2 |
8.081400E-01 |
| Stage1-vs-Stage3 |
9.939000E-01 |
| Stage1-vs-Stage4 |
8.139800E-01 |
| Stage2-vs-Stage3 |
8.088200E-01 |
| Stage2-vs-Stage4 |
9.618000E-01 |
| Stage3-vs-Stage4 |
8.368200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.80371298294813E-12 |
| Normal-vs-AfricanAmerican |
8.31709999982166E-07 |
| Normal-vs-Asian |
6.81850000017192E-07 |
| Caucasian-vs-AfricanAmerican |
3.008000E-01 |
| Caucasian-vs-Asian |
6.172600E-01 |
| AfricanAmerican-vs-Asian |
1.739580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51889945065875E-10 |
| Normal-vs-Female |
1.70108371833066E-12 |
| Male-vs-Female |
6.907200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.14306350443394E-12 |
| Normal-vs-Age(41-60Yrs) |
5.86469761643116E-11 |
| Normal-vs-Age(61-80Yrs) |
5.63859958724322E-10 |
| Normal-vs-Age(81-100Yrs) |
2.157600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.197800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.137400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.937600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.470600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.310400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.728400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.639840E-01 |
| Classical-VS-Follicular |
8.752000E-02 |
| Classical-VS-Other |
5.006000E-01 |
| Classical-VS-Normal |
1.69086966650411E-12 |
| Tall-VS-Follicular |
1.164450E-02 |
| Tall-VS-Other |
7.904800E-01 |
| Tall-VS-Normal |
4.17019999999768E-05 |
| Follicular-VS-Other |
1.520000E-01 |
| Follicular-VS-Normal |
6.42029762687457E-11 |
| Other-VS-Normal |
1.108980E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.20774526332934E-14 |
| Normal-vs-N1 |
1.18849999997117E-06 |
| N0-vs-N1 |
2.020600E-01 |
|
|
